C. Trépo

871 total citations
31 papers, 675 citations indexed

About

C. Trépo is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, C. Trépo has authored 31 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 18 papers in Hepatology and 9 papers in Infectious Diseases. Recurrent topics in C. Trépo's work include Hepatitis B Virus Studies (15 papers), Hepatitis C virus research (15 papers) and Liver Disease Diagnosis and Treatment (7 papers). C. Trépo is often cited by papers focused on Hepatitis B Virus Studies (15 papers), Hepatitis C virus research (15 papers) and Liver Disease Diagnosis and Treatment (7 papers). C. Trépo collaborates with scholars based in France, Brazil and Czechia. C. Trépo's co-authors include Fabien Zoulim, O. Hantz, P. Chossegros, Denis Ouzan, Janice K. Albrecht, Carlton Meschievitz, Thierry Fontanges, Xavier Causse, L. Vitvitski and Lucyna Cova and has published in prestigious journals such as Gastroenterology, Hepatology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

C. Trépo

31 papers receiving 651 citations

Peers

Countries citing papers authored by C. Trépo

Since Specialization

Citations

This map shows the geographic impact of C. Trépo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Trépo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Trépo more than expected).

Fields of papers citing papers by C. Trépo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Trépo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Trépo. The network helps show where C. Trépo may publish in the future.

Co-authorship network of co-authors of C. Trépo

This figure shows the co-authorship network connecting the top 25 collaborators of C. Trépo. A scholar is included among the top collaborators of C. Trépo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Trépo. C. Trépo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Vitro Activity of 2,4-Diamino-6-[2-(Phosphonomethoxy)Ethoxy]-Pyrimidine against Multidrug-Resistant Hepatitis B Virus Mutants 2007 ·Antimicrobial Agents and Chemotherapy ·(unknown), Julie Lucifora, Johan Neyts, Stéphanie Villet, Antonı́n Holý, C. Trépo, Fabien Zoulim	36
2	A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine 2006 ·Journal of Viral Hepatitis ·Fabien Zoulim, Thierry Poynard, Françoise Degos, (unknown), Abdelkader El Hasnaoui, Patrick Blin, François Mercier, Paul Dény, Paul Landais, Parviz Parvaz, C. Trépo, (unknown)	53
3	O.168 Rolling circle amplification technology for the study of HBV variants 2006 ·Journal of Clinical Virology ·(unknown), S. Durantel, Isabelle Chemin, Luc Barraud, Fabien Zoulim, C. Trépo, Alan Kay	1
4	Initial Amplification of Duck Hepatitis B Virus Covalently Closed Circular Dna After In Vitro Infection of Embryonic Duck Hepatocytes Is Increased by Cell Cycle Progression 2001 ·Hepatology ·Christelle Borel, Olivier Schorr, Isabelle Durand, Fabien Zoulim, Alan Kay, C. Trépo, O. Hantz	18
5	The SATE pronucleotide approach applied to acyclovirPart II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo 1999 ·Antiviral Research ·O. Hantz, Christian Périgaud, Christelle Borel, Catherine Jamard, Fabien Zoulim, C. Trépo, Jean‐Louis Imbach, (unknown)	16
6	[Do general practitioners want to manage chronic hepatitis C and take part in hepatitis C health networks? A national survey]. 1999 ·PubMed ·G Babany, Marc Bourlière, H Chevalier, M Chousterman, (unknown), Hervé Desmorat, Daniel Dhumeaux, M Doffoël, Jérôme Gournay, (unknown), (unknown), J. Moussalli, C. Trépo, Gilbert Tucat, Diep Tran, (unknown)	5
7	[National study of screening practices for hepatitis C among hemodialysis patients. Hepatitis Group]. 1998 ·PubMed ·(unknown), (unknown), Cyrille Colin, (unknown), (unknown), François Bailly, (unknown), M Labeeuw, C. Trépo	2
8	Phosphorylation of DHBV Pre-S: Identification of the Major Site of Phosphorylation and Effects of Mutations on the Virus Life Cycle 1998 ·Virology ·Christelle Borel, Claire Sunyach, O. Hantz, C. Trépo, Alan Kay	20
9	Human Hepatocellular Carcinoma Transplanted in Nude Mice: A Relevant Experimental Model to Assess Tumoral Destruction by Alcoholization 1994 ·Journal of Surgical Research ·(unknown), C Gouillat, Suzanne Bertrand, Isabelle Fourel, (unknown), (unknown), C. Trépo	4
10	Pre-core mutation associated with lack of hepatitis B e antigenaemia in Moroccan asymptomatic carriers of the virus 1993 ·Research in Virology ·Soumaya Benjelloun, Shuping Tong, (unknown), (unknown), C. Trépo, (unknown)	7
11	Effects of 2′‐fluorinated arabinosyl‐pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks 1992 ·Journal of Medical Virology ·Isabelle Fourel, (unknown), O. Hantz, Chantal Jacquet, Jack J. Fox, C. Trépo	36
12	Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis 1991 ·Gastroenterology ·Xavier Causse, (unknown), (unknown), P. Chossegros, Fabien Zoulim, Denis Ouzan, (unknown), Thierry Fontanges, Janice K. Albrecht, Carlton Meschievitz, C. Trépo	222
13	Plasma viraemia as a marker of viral replication in HIV-infected individuals 1991 ·AIDS ·Sonia Escaich, (unknown), (unknown), (unknown), J P Lamelin, (unknown), C. Trépo	28
14	[Association of sacral chordoma and mature testicular teratoma]. 1991 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), C. Trépo, (unknown)	4
15	Natural and experimental infection of wild mallard ducks with duck hepatitis B virus 1991 ·Journal of General Virology ·Véronique Lambert, Lucyna Cova, (unknown), Ravi Mehrotra, C. Trépo	10
16	Detection of pre-S1 antigen in PBMC and serum of anti-HBc-positive chronic HBs Ag carriers: A relevant tool for the decision of antiviral therapy 1989 ·Journal of Hepatology ·Fabien Zoulim, Marie Petit, L. Vitvitski, F. Capel, (unknown), C. Trépo	2
17	Based on Your Analysis of the Benefits and Costs of RoutineDonor Screening for ALT-GPT to Reduce the Incidence ofPost-Transfusion Non-A, Non-B Hepatitis in Your BloodServices Region, what Action Would You Recommend onThis Matter? 1983 ·Vox Sanguinis ·Richard D. Aach, William L. Bayer, Robert J. Gerety, Paul V. Holland, D. B. L. McClelland, R. Mitchell, Ralf Müller, H.W. Reesink, E.E. Reerink‐Brongers, C. Trépo, (unknown), (unknown), J Ducos	6
18	Should Donors with a History of Jaundice Still be Rejected? 1981 ·Vox Sanguinis ·Richard D. Aach, Harrison Alter, L. F. Barker, G. W. G. Bird, Anne Couroucé, Michael Goldfield, G. Papaevangelou, H.W. Reesink, V. Reinicke, L. B. Seeff, C. Trépo, (unknown)	2
19	Hépatite et varicelle. A propos d'un cas. 1978 ·Annales de Dermatologie et de Vénéréologie ·J.‐P. Ortonne, (unknown), C. Trépo, (unknown), J Thivolet	1
20	[Primary biliary cirrhosis and Australia antigen]. 1971 ·PubMed ·(unknown), (unknown), (unknown), C. Trépo, J Caroli	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact